Work

Abstract 7060: Targeting KMT2C induces paralog synthetic lethality in KMT2D null DLBCL through DREAM targets regulation.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7060

Authors: Hsiangyu Hu, Neeraj K. Aryal, Tim Nieuwenhuis, Daniel Barrell, Ultan McDermott, Laura B. Prickett, Ming Tang, Derek Oien, Laura Pasqualucci, Anas Younes, Lisa Drew, Omid Tavana

Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom), Columbia University

Language: English

Topic: Chromatin Remodeling and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148799750

Cites:

Cited by:

Related to: